Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)

This study is currently recruiting participants.
Verified January 2013 by University of Ulm
Sponsor:
Information provided by (Responsible Party):
Jochen Greiner, University of Ulm
ClinicalTrials.gov Identifier:
NCT01770158
First received: October 9, 2012
Last updated: January 14, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)